Introduction: The common genetic variant (rs1051730) in the 15q24 nicotinic acetylcholine
INTRODUCTION
Maternal smoking during pregnancy continues to be a public health issue in developed countries and in an increasing number of developing countries [1] [2] [3] [4] [5] . Although the true prevalence of smoking during pregnancy is difficult to discern, in recent studies this prevalence varies worldwide with estimates well below 10% in high-income countries such as Australia, Canada, the UK and the US 6 and higher prevalence in low-and middle-income countries like Uruguay (18.3%) 7 and Romania (15%) 8 .
Smoking during pregnancy appears to have decreased steadily in recent years. Numbers may vary reflecting some variation between studies in the way the questions concerning the prevalence were posed, but overall prevalence rates among pregnant women declined from the sixties onwards. One reason for the decline in the rates of smoking during pregnancy is probably the increase in awareness of the health risks to both mother and child of smoking.
Many studies have shown that tobacco smoke during pregnancy can cause serious health and behavioral issues for a developing fetus and/or infant [9] [10] [11] . For example, maternal smoking increased the risk of stillbirths, preterm birth and low birth weight, and sudden infant death syndrome 12 . Later, these offspring were at increased risk for neurodevelopmental disorders such as ADHD (Attention Deficit Hyperactivity Disorder) 13 , externalizing behavior, aggression, overactive and withdrawn behavior 13, 14 , and obesity 15 . Thus, quitting smoking before pregnancy reduces the child's health risks and the risk of complications during delivery.
Smoking behavior aggregates in families, and heritability estimates for different stages of smoking behavior vary from 33% for smoking initiation to 86% for nicotine dependence M a n u s c r i p t subunit genes [19] [20] [21] , as was first explained on a genome-wide significant level 22 . The CHRNA5-CHRNA3-CHRNB4 gene cluster on chromosome 15q25.1, encoding the alpha5, alpha3, beta4 subunits, has provided the best established genetic evidence; first in relation to the amount smoked (cigarette per day (CPD)) and subsequently in relation to other smokingrelated phenotypes (e.g., nicotine dependence, smoking cessation) as well as smoking-related diseases (e.g., lung cancer and chronic obstructive pulmonary disease) [23] [24] [25] [26] [27] [28] . However, there is no association with smoking initiation 20 . The association between this gene cluster and smoking cessation treatment is inconsistent [29] [30] [31] .
Specifically, two SNPs rs1051730 (CHRNA3) and rs16969968 (CHRNA5) in perfect LD (D'=1, r 2 =1), have consistently been associated with nicotine dependence and CPD. Not only was this locus the top-result in the meta-analyses described above, but it was also strongly associated with nicotine dependence in other studies 32 . Notably, rs16969968 is a missense mutation, resulting in an amino acid change (aspartate to asparagine) in the resultant alpha-5 nicotinic receptor subunit protein. This change is associated with reduced receptor function in vitro 33 . Few studies have examined the association between this locus and smoking cessation during pregnancy. Freathy et al. 34 found an association of rs1051730 and smoking cessation in 2,474 pregnant women, which was replicated in a case-control study of 1,891 pregnant women 35 .
In addition to genetic factors, demographic and contextual factors also seem to play a role in smoking behavior of pregnant women. Smoking status of the partner has been shown to be important in smoking behavior 36, 37 and in smoking cessation 38 . More recent research has pointed to a positive effect on smoking cessation in pregnant women of having no one in M a n u s c r i p t 5 the vicinity smoke, and of having a smoking ban in the home 39, 40 The aim of this study was to explore the association between rs1051730 risk allele (T) and smoking during pregnancy in a sample of Dutch women (N=1,337) registered at the Netherlands Twin Register (NTR). In addition, we investigated the influence of the partner's smoking behavior (N=561 spouses) in combination with genotype of the pregnant woman on smoking during pregnancy.
METHODS

The Netherlands Twin Register -participants
The Netherlands Twin Register (NTR) includes twins and their family members who participated in longitudinal research projects. Young twins (YNTR) were registered at birth by their parents. Demographic characteristics, recruitment and data collection procedures in these samples have been described in detail elsewhere 43 44 , and a group of sisters who were both mothers of DZ twins were invited to participate in a 'DZ twinning project'. A large group of subjects also participated in the NTR A c c e p t e d M a n u s c r i p t 6 Biobank study, between 2004 to 2008, during which DNA samples and other biological material were collected. Details were described elsewhere 45 .
Smoking during pregnancy
The following NTR survey studies included questions on smoking during pregnancy: ANTR been demonstrated that the inclusion of non-confounding covariates in logistic regression of general population samples, in contrast to ascertained case-control samples, increases the power of association testing 46, 47 .
Genotyping
The rs1051730 SNP was genotyped using standard methods, details of which were presented previously in Mbarek et al. 48 . The observed genotyped counts in the present study did not differ significantly from those expected under the Hardy-Weinberg equilibrium (CC = 605, 45.3%, CT = 596, 44.6%, and TT = 136, 10.2%; for women who smoked during pregnancy and women who did not smoke during pregnancy p > .1).
Statistical analyses
We performed logistic regression to test for the effects of rs1051730 genotype on smoking during pregnancy (counts were comparable for women who did and did not smoke during pregnancy). The genotype was coded as 0 versus 1 or 2 copies of the T (risk) allele because the number of participants with 2 copies of the T allele was relatively low. Analyses were performed with and without adjustment for birth cohort and educational attainment. However, we considered the analyses with covariate as the analyses of choice, as the covariates are nonconfounding, and the sample is a population sample (i.e., not ascertained as in a case control M a n u s c r i p t 8 study). In this specific setting, the analyses with covariates is more powerful than the analyses without the covariates 46, 47 .
In a subsample we explored the influence of partner's smoking with and without the risk alleles on smoking during pregnancy with adjustment for birth cohort and educational attainment. Analyses were done using SPSS version 21.0 (SPSS Inc., Chicago, IL).
RESULTS
In the total sample of 1,337 women who ever smoked, 461 smoked during pregnancy (34.5%) In the total sample of 1,337 women who ever smoked, there was evidence for a significant association between having 1 or more T alleles of the rs1051730 polymorphism and the likelihood of smoking during pregnancy (OR = 1.28, 95% CI 1.02-1.61, p = 0.03, Table 1 ).
However, this association was attenuated when adjusting for birth cohort and educational attainment (OR = 1.12, 95% CI 0.87-1.43, p = 0.37, Table 1 ). The probability of smoking during pregnancy was lower in women with a higher education. This association remained significant in the present analyses. These variables together explain 4.6% of the variance in smoking cessation during pregnancy. A c c e p t e d M a n u s c r i p t Next, we included smoking behavior of the spouse during pregnancy in the model. In the group of women who had a non-smoking spouse the probability of smoking was almost two times higher (OR 1.92) for women with 1 or 2 risk alleles compared to women with no risk alleles, although the difference was not statistically significant (p=0.056). When having a smoking spouse, the risk of smoking during pregnancy was more than 5 times higher (OR 5.55 for group with no risk alleles and OR 5.70 for group with 1 or 2 risk alleles) regardless of genotype ( Table 2 ). There was no significant difference between these last two groups with regard to the risk of smoking during pregnancy. So having a smoking spouse was highly associated with smoking during pregnancy, even when educational attainment and birth cohort were included in the model. We also tested for an interaction between genotype and education on cessation, and found a significant interaction for the low and middle education levels but not for the high education level (results not shown). All variables together (Table 2) explained 17.5% of the variance in smoking during pregnancy but the largest part of the explained variance came from having a smoking spouse. Finally we performed a sensitivity analysis by imputing the missing data in the subsample, the results were similar before and after imputation with one exception for the effect year of birth which was not significant (see Supplemental Table S2 ).
DISCUSSION
To our knowledge, our study included the largest replication sample in order to investigate the association of rs1051730 and smoking cessation during pregnancy taking into account birth cohort and educational attainment level, and in a subsample also partner's smoking status. We
were not able to reproduce Freathy et al. 34 and Thorgeirsson et al., 35 findings of association between rs1051730 variant and smoking during pregnancy. We did observe an association without adjustment for birth cohort and educational attainment level (p=0.03). However, M a n u s c r i p t 10 adjusting for these covariates rendered the association not significant (p=0.37). As the analyses with covariate has greater power 46, 47 in the present setting, we conclude that there is no association. This is in contrast with a meta-analyses (in 24 studies of European ancestry, N=29,072)
showing a lower likelihood of smoking cessation for the rs16969968 A allele. The AA genotype was also associated with a four-year delay in median age of quitting compared with the GG genotype 27 .
Interestingly, in our study, the smoking behavior of the spouse was strongly associated with smoking in pregnant women. The effect of genotype did not reach statistical significance (OR 1.92, p=0.056) on smoking during pregnancy in the group of women with a non-smoking spouse, however the possible genetic effect seemed totally overruled by having a smoking partner in the other groups (OR > 5 for women with and without the risk genotype).
Spousal similarity in smoking behavior has been shown in a Dutch study of current smoking behavior 49 but the present study emphasized the importance of social influences like spousal smoking on smoking behavior of pregnant women.
Our study did also have some limitations: (i) Some of our participants might have given up smoking years before they were pregnant. Therefore the effect sizes are likely to be smaller than those observed in the paper of Freathy et al. 34 , who restricted analyses to women smoking regularly just prior to pregnancy. (ii) We did not stratify the analysis by smoking period during pregnancy due to small sample size for each period. (iii) there are many other nongenetic factors that influence smoking cessation during pregnancy, including environmental factors and psychological factors (e.g. concurrent alcohol use, financial status, internalizing and externalizing problems), which were not taken into account in the present study. (iv) Although we used the largest sample to date to test the interaction between partner M a n u s c r i p t 11 smoking and the rs1051730 genotype, it is likely that a larger sample is required in order to ensure sufficient power to detect an interaction effect.
To conclude, our results did not support a strong association between this genetic variant and smoking during pregnancy. However, a strong association was observed with smoking behavior of the partner, regardless of the genotype of the women. Further research is needed to address the role of this and other genetic factors in influencing smoking cessation and their interaction with important environmental factors like smoking behavior of the partner.
Knowledge of these genetic factors will help to identify mothers at risk early on and reduce their risk for nicotine dependence and its related negative health consequences on the mother and the child [50] [51] [52] [53] . 
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